Modelling and enhanced molecular dynamics to steer structure-based drug discovery.

Area of Science:

• Biochemistry
• Computational Biology
• Structural Biology

Background:

• The gap between available genome sequences and protein crystal structures poses a challenge for drug discovery.
• Understanding protein structure, dynamics, and function is vital for structure-based drug design.
• Key aspects include drug-protein interactions, binding/unbinding mechanisms, and protein-protein interactions.

Purpose of the Study:

• To review state-of-the-art computational approaches for protein structure modeling.
• To discuss the application of molecular dynamics (MD) simulations in biological systems.
• To highlight how enhanced sampling MD methods aid structure-based drug discovery.

Main Methods:

• Protein structure modeling techniques.
• Molecular dynamics (MD) simulations.
• Enhanced sampling MD approaches.

Main Results:

• Computational methods bridge the gap between genomic data and structural information.
• MD simulations provide insights into protein dynamics and function.
• Enhanced sampling accelerates the exploration of biologically relevant conformational states.

Conclusions:

• Computational approaches, particularly MD simulations, are essential tools in modern drug discovery.
• Enhanced sampling methods significantly improve the efficiency of studying protein dynamics.
• These techniques facilitate a deeper understanding of drug-target interactions and mechanisms.